Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma
about
Vorinostat, Bortezomib, and Doxorubicin Hydrochloride Liposome in Treating Patients With Relapsed or Refractory Multiple Myeloma
description
clinical trial
@en
klinisch onderzoek
@nl
name
Vorinostat, Bortezomib, and Do ...... or Refractory Multiple Myeloma
@en
type
label
Vorinostat, Bortezomib, and Do ...... or Refractory Multiple Myeloma
@en
prefLabel
Vorinostat, Bortezomib, and Do ...... or Refractory Multiple Myeloma
@en
P4844
P1476
A Phase 1 Dose Escalation Stud ...... se/Refractory Multiple Myeloma
@en
P3098
NCT00744354
P580
2008-10-01T00:00:00Z
P582
2011-12-01T00:00:00Z